Motivated by the role of CSCs in chemoresistance [13, 14], we quantified the expression of several prominent CSC gene markers in colorectal cancer, i.e., ALDH1A3, CD166, CD133, and LGR5, following each cycle of treatment [22–24]. Here, PROM1 is linked to colorectal cancer.